Anika Therapeutics, Inc. Number of Reportable Segments
Anika Therapeutics, Inc. (ANIK) reported Number of Reportable Segments of 100.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-07-29
- Anika Therapeutics, Inc. number of reportable segments for the quarter ending 2017-03-31 was 100.00%, a 0.00% change year-over-year.
- Anika Therapeutics, Inc. number of reportable segments for the quarter ending 2016-03-31 was 100.00%, a 0.00% change year-over-year.
- Anika Therapeutics, Inc. number of reportable segments for the quarter ending 2015-03-31 was 100.00%, a 0.00% change year-over-year.
- Anika Therapeutics, Inc. number of reportable segments for the quarter ending 2014-03-31 was 100.00%.
- Anika Therapeutics, Inc. number of reportable segments for fiscal 2020 was 100.00%, a 0.00% change from fiscal 2019.
- Anika Therapeutics, Inc. number of reportable segments for fiscal 2019 was 100.00%, a 0.00% change from fiscal 2018.
- Anika Therapeutics, Inc. number of reportable segments for fiscal 2018 was 100.00%.
- Anika Therapeutics, Inc. number of reportable segments for fiscal 2016 was 100.00%, a 0.00% change from fiscal 2015.
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.00% 10-Q · filed 2026-07-29 | |||
| 2020-12-31 | 100.00% 10-K · filed 2021-03-05 | |||
| 2019-12-31 | 100.00% 10-K · filed 2020-03-06 | |||
| 2018-12-31 | 100.00% 10-K · filed 2019-02-27 | |||
| 2017-09-30 | 100.00% 10-Q · filed 2017-10-27 | |||
| 2017-06-30 | 100.00% 10-Q · filed 2017-07-28 | |||
| 2017-03-31 | 100.00% 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | 100.00% 10-K · filed 2017-02-24 | |||
| 2016-09-30 | 100.00% 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | 100.00% 10-Q · filed 2016-08-01 | |||
| 2016-03-31 | 100.00% 10-Q · filed 2016-05-03 | |||
| 2015-12-31 | 100.00% 10-K · filed 2016-03-10 | |||
| 2015-09-30 | 100.00% 10-Q · filed 2015-11-03 | |||
| 2015-06-30 | 100.00% 10-Q · filed 2015-08-04 | |||
| 2015-03-31 | 100.00% 10-Q · filed 2015-05-04 | |||
| 2014-12-31 | 100.00% 10-K · filed 2015-03-13 | |||
| 2014-09-30 | 100.00% 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | 100.00% 10-Q · filed 2014-08-04 | |||
| 2014-03-31 | 100.00% 10-Q · filed 2014-05-05 | |||
| 2013-12-31 | 100.00% 10-K · filed 2014-03-13 | |||
| 2013-09-30 | 100.00% 10-Q · filed 2013-11-05 |
Segment
| Period end | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2012-12-31 | 1.00 Segment 10-K · filed 2013-03-14 | |
| 2012-09-30 | 1.00 Segment 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |